Efficacy of inhaled molgramostim according to severity of autoimmune pulmonary alveolar proteinosis (aPAP) - Amsterdam 2025

Alveolar filling disorders and autoimmune lung diseases

Chair(s): Stéphane Jouneau, Helen O'Brien

Session type: Poster session

Efficacy of inhaled molgramostim according to severity of autoimmune pulmonary alveolar proteinosis (aPAP)

Cormac McCarthy

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

A novel, rapid, and effective cardiopulmonary bypass-based technique for whole lung lavage in pulmonary alveolar proteinosis and silicosis.

Eviatar Naamany

Poster

Abstract

Development of a dried serum assay for the detection of GM-CSF antibodies to aid in the diagnosis of autoimmune pulmonary alveolar proteinosis (aPAP)

Eagappanath Thiruppathi

Abstract

Late Breaking Abstract - Radiological Progression of Interstitial Lung Abnormalities

Min Zhu

Poster

Abstract

Late Breaking Abstract - DGUOK dysfunction as a monogenetic cause of pleuroparenchymal fibroelastosis with onset in childhood.

Nicolaus Schwerk

Poster

Abstract

Late Breaking Abstract - Determinants of Non-Persistence to Antifibrotic Therapy in Real-World Clinical Practice in the French population

Vincent Cottin

Poster

Abstract

Pulmonary involvement in patients with primary antibody deficiency the results from a multicentric cross-sectional study

Tomas Milota

Poster

Abstract

Peri-cystic lesions in ANCA-associated fibrosing interstitial lung disease

Lucas Bayart

Poster

Abstract

Monitoring of Systemic Autoimmune Rheumatic Disease Interstitial Lung Disease (SARD-ILD) with Remote Spirometry

Ahmed Fahim

Poster

Abstract

Clinical Outcomes and Quantitative Imaging Patterns of Fibrotic Pulmonary Alveolar Proteinosis: A Large-scale, Longitudinal Chinese Cohort

Junfeng Huang

Poster

Abstract

Screening for acid sphingomyelinase deficiency in patients with an interstitial lung disease

Marie Vermant

Poster

Abstract

Clinical Trial of Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Autoimmune Pulmonary Alveolar Proteinosis

Xinyu Song

Poster

Abstract

A case series of pulmonary alveolar proteinosis (PAP) and hypersensitivity pneumonitis (HP) overlap

Jessica Raja

Poster

Abstract

Idiopathic pulmonary hemosiderosis: a case series highlighting diagnostic and therapeutic challenges

Maria Clara Maricoto Monteiro

Poster

Abstract

Relationship between pulmonary gas transfer, respiratory health-related quality of life (HRQoL), exercise capacity, and surfactant burden in autoimmune pulmonary alveolar proteinosis (aPAP)

Francesco Bonella

Poster

Abstract

Efficacy of inhaled molgramostim according to severity of autoimmune pulmonary alveolar proteinosis (aPAP)

Cormac Mccarthy

Poster

Abstract

Pulmonary Alveolar Proteinosis: a 3-country cohort study Greece, Türkiye, Cyprus

Effrosyni D. Manali

Poster

Abstract

Pulmonary alveolar microlithiasis with a novel genetic variant: a case report

Anna Lindahl

Poster

Abstract

Interstitial lung involvement in Acid Sphingomyelinase deficit (ASMD): clinical case series.

Marta Garcia Moyano

Poster

Abstract

Clinical characteristics and survival in patients with pulmonary alveolar proteinosis (PAP) with and without pulmonary fibrosis.

Karol Baczek

Poster

Abstract

Late Breaking Abstract - Synthetic Arm Generation Utilizing Real-World Patient Data Demonstrates Treatment Effect in the Phase 2a AIR trial of Buloxibutid in IPF

Muhunthan Thillai

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}